US Archives - Page 5 of 182 - European Medical Journal

Elderly woman with back pain examined by doctor in medical clinic.

Arthralgia Criteria Improves Rheumatoid Arthritis Prediction

Rheumatoid arthritis risk criteria may help identify which patients with arthralgia are most likely to progress.

Patient with alopecia areata in consultation with a healthcare professional

AAD 2026: Strong Week 24 Outcomes in Severe Alopecia Areata

Patients with severe alopecia areata treated with upadacitinib achieved greater hair regrowth at Week 24 versus placebo.

Male patient discussing breast cancer treatment options with a clinician

Male Breast Cancer Tool Predicts Chemotherapy Benefit

Male breast cancer risk stratification may help identify which patients with luminal early disease benefit from chemotherapy.

Physiotherapist supporting a stroke survivor during seated trunk control rehabilitation

Stroke Trunk Control Linked to Muscle Stiffness

Stroke trunk control in acute ischemic stroke may be closely linked to resting posterior trunk muscle tone and stiffness.

Visible atopic dermatitis rash on the knees of a pediatric patient

AAD 2026: Long-Term Upadacitinib Safety Seen Across Ages

Patients with moderate-to-severe atopic dermatitis showed generally low long-term upadacitinib safety event rates across ages.

Youth advisory board discussion supporting HIV research planning in a low and middle income country

How Youth Advisory Boards Inform HIV Research

Youth advisory boards in HIV research remain under-evaluated, despite shaping study planning, implementation, and community engagement.

Patient with hidradenitis suppurativa symptoms affecting the underarm area

AAD 2026: Four Years of Secukinumab Sustains HS Control

Continuous secukinumab treatment showed sustained hidradenitis suppurativa lesion control through 4 years in responding patients.

Sick baby boy on a hospital bed applying inhale medication to cure RSV.

Nirsevimab Linked to Lower RSV Hospitalization

Nirsevimab was linked to fewer RSV hospitalizations and severe neonatal outcomes than maternal RSVpreF vaccination in France.

Adult woman scratching upper arm to illustrate itch associated with chronic spontaneous urticaria

AAD 2026: Remibrutinib Shows Early CSU Symptom Relief

Remibrutinib improved itch and hive severity within 12 hours in chronic spontaneous urticaria in Phase III analysis.

Elderly patient speaking with a doctor during a medical consultation about memory concerns

Cerebral Lymphatic Therapy Advances Alzheimer’s Disease

Cerebral lymphatic dysfunction is emerging as a promising therapeutic target in Alzheimer’s disease treatment and research.